Related references
Note: Only part of the references are listed.What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies
Gabriela Patten et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
Ravindra K. Gupta et al.
LANCET INFECTIOUS DISEASES (2018)
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali
Claudia S. Crowell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
Alexander J. Szubert et al.
PLOS MEDICINE (2017)
Virologic Failure Among Children Taking Lopinavir/Ritonavir-containing First-line Antiretroviral Therapy in South Africa
Tammy Meyers et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa
Theresa M. Rossouw et al.
PLOS ONE (2015)
Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure
George W. Rutherford et al.
AIDS (2014)
Long-Term Virologic Response and Genotypic Resistance Mutations in HIV-1 Infected Kenyan Children on Combination Antiretroviral Therapy
Dalton C. Wamalwa et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Development of Antiretroviral Resistance in Children With HIV in Low- and Middle-Income Countries
Felicity Fitzgerald et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Determinants of HIV drug resistance and public health implications in low- and middle-income countries
Silvia Bertagnolio et al.
ANTIVIRAL THERAPY (2012)
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial
Abdel Babiker et al.
LANCET INFECTIOUS DISEASES (2011)
Share Paper
